Events › B2B Event
B2B Event
15th edition
The 15th Tumour Models London Summit is a focused industry event for preclinical oncology researchers, exploring advancements in patient-derived models, immuno-oncology, and AI-driven image analysis to improve drug translation.
Filter this event to your ICP.
Dozens of solution providers here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
⚠️ The exhibitor list for this event isn't publicly accessible yet. We'll work on it once you submit a request.
Organizer
Hanson WadePE-backed · London, United Kingdom · Founded 2008
Hanson Wade is a global conference organizer and market intelligence provider focused primarily on the life sciences and biopharma sectors.
Why people attend
To find specialized CRO partners for in vivo and in vitro tumor models, and to evaluate new, predictive preclinical technologies for drug discovery pipelines.
Exhibitor categories
Sample matches
Filtered to a Series-B SaaS ICP. Your filter will be different.
Sample Match A
example.com
"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."
Sample Match B
example.io
"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
Speakers
26 speakers at Tumour Models London Summit
Director of Preclinical Models & Services · GenOway
"Advancing Translational Immuno-Oncology: Tumor–Immune Dynamics and Predictive Humanized Models for Immunotherapies"
ISF College of Pharmacy, India
"Fireside Chat: Examining the Future of Tumour Modelling"
Also speaking at 3rd Information Technology Conference, 5th Digital Marketing, Advertising & Technology Confex, 12th Edition of International Conference on Neurology and Neurological Disorders
Director - Bioinformatics & Data Science · Certis Oncology
"Preclinical Cancer Research in the Age of Reduced Animal Use & Artificial Intelligence"
Also speaking at 14th Tumor Models Boston Summit
Head of Oncology · GemPharmatech
"Preclinical Strategies to Evaluate T-Cell Engagers"
Also speaking at Network and Distributed System Security Symposium, Global Conference on Plant Science and Molecular Biology
Associate Director, Scientific Communications · ChemPartner Corporation
"Advancing ADC Research: Smarter Designs Driving Translational Success"
Scientific Director, Pathology · Janssen
"Advancing Autologous CAR-T Cell Therapy Development Through Translatable in Vivo Murine Xenograft Tumour Models: A Pathologist’s Perspective"
VP of Biology, Head of Scientific Engagement · LIDE
"A Translational Approach to Evaluate T Cell Engagers & Bispecific Antibodies in Humanised Animal Models"
Chief Executive Officer · HUB Organoids (A Merck Company)
"Translating Tumor Complexity: How Organoids Are Shaping the Future of Clinical Oncology"
Head of operations · ERBC Group
"Rethink In Vivo Oncology Screening: Rapid. Relevant. Responsible"
Director of Welfare and Compliance · AstraZeneca
Director · AstraZeneca
Principal Scientist · Avacta Therapeutics
Project Manager · Gustave Roussy
Vice President Head of Translational Sciences · Ipsen Pharma
Global Animal Welfare Officer EMEA & APAC · Merck KGaA
Principal Scicentist II · Novartis AG
+ 10 more speakers at this event.
More events in United Kingdom
Frequently asked questions